Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 15, 2013
Lifestyle factors correlate with the risk of late pelvic symptoms after prostatic radiotherapyR J Thomas, M Holm, M Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 13, 2003
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studiesM Kelleher, N C Tebbutt, D Cunningham, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 10, 2011
Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologistsC C Henson, H J Andreyev, R P Symonds, et al.
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.
Gut|March 13, 2003
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastasesN C Tebbutt, A R Norman, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)H J Andreyev, A R Norman, D Cunningham, et al.
British Journal of Cancer|January 1, 1997
Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomasH J Schneider, S A Sampson, D Cunningham, et al.
Gut|February 12, 1998
K-ras mutations in patients with early colorectal cancersH J Andreyev, J V Tilsed, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumorsH J Andreyev, P Scott-Mackie, D Cunningham, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancerD J J Farnell, J Staffurth, S Sivell, et al.
Pageof 3